Print Page  |  Close Window

SEC
10-Q
BIOTELEMETRY, INC. filed this Form 10-Q on 10/31/2018
Entire Document
 << Previous Page | Next Page >>
PART I — FINANCIAL INFORMATION


Item 1.  Financial Statements
BIOTELEMETRY, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and par value amounts)
(Unaudited)
September 30,
2018
 
December 31,
2017
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
63,118

 
$
36,022

Healthcare accounts receivable, net of allowance for doubtful accounts of $22,943 and $15,556, at September 30, 2018 and December 31, 2017, respectively
36,414

 
25,190

Other accounts receivable, net of allowance for doubtful accounts of $2,136 and $1,425, at September 30, 2018 and December 31, 2017, respectively
14,609

 
13,296

Inventory
8,786

 
5,332

Prepaid expenses and other current assets
11,065

 
10,268

Total current assets
133,992

 
90,108

Property and equipment, net of accumulated depreciation of $66,639 and $71,902, at September 30, 2018 and December 31, 2017, respectively
47,770

 
49,194

Intangible assets
130,334

 
141,707

Goodwill
238,339

 
223,105

Deferred tax assets
21,830

 
17,681

Other assets
1,941

 
2,767

Total assets
$
574,206

 
$
524,562

LIABILITIES AND EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
15,502

 
$
14,529

Accrued liabilities
24,104

 
26,055

Current portion of capital lease obligations
2,290

 
4,023

Current portion of long-term debt
4,356

 
2,050

Deferred revenue
3,833

 
4,298

Total current liabilities
50,085

 
50,955

Long-term portion of capital lease obligations
214

 
1,486

Long-term debt
194,395

 
197,306

Other long-term liabilities
33,997

 
25,112

Total liabilities
278,691

 
274,859

Stockholders’ equity:
 

 
 

Common stock—$.001 par value as of September 30, 2018 and December 31, 2017; 200,000,000 shares authorized as of September 30, 2018 and December 31, 2017; 33,212,058 and 32,460,668 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively
33

 
32

Paid-in capital
422,041

 
409,517

Accumulated other comprehensive loss
(308
)
 
(114
)
Accumulated deficit
(126,251
)
 
(158,678
)
Total BioTelemetry, Inc.’s stockholders’ equity
295,515

 
250,757

Noncontrolling interest

 
(1,054
)
Total equity
295,515

 
249,703

Total liabilities and equity
$
574,206

 
$
524,562

See accompanying Notes to Consolidated Financial Statements.

4

 << Previous Page | Next Page >>